| Management target | Revenue 100.0% FY30 |
|---|
| Revenue growth | 20.01% YoY in Q1 FY27. |
|---|---|
| Margins | EBITDA margin 24.6%; expected to sustain north of 20%. |
| Order book | Long-term contracts with Givaudan, P&G, and Henkel. |
| Demand visibility | Broad-based demand across domestic and export markets. |
| Management confidence | High; citing resilience and structural business strength. |
Growth
Revenue grew 20.01% YoY to Rs 681.42 Cr; Net Profit surged 35.97% YoY to Rs 84.21 Cr.
Outlook
Targeting Rs 5,000 Cr revenue and Rs 1,000 Cr+ EBITDA by FY29-30. Expansion projects operational by H2 2028.
Risks
One-off fire loss of Rs 2.78 Cr; adverse global headwinds and potential supply chain vulnerabilities mentioned.
Last quarter's promises, checked
Delivered
- Guided 20% revenue growth → delivered 20.01% (= BEAT)
- Guided 20%+ EBITDA margins → delivered 24.6% (= BEAT)
- Guided PRIGIV JV profitability → delivered Q1 FY27 profits (= BEAT)
Partly delivered
- Guided Phase 1 capex completion by June 30, 2026 → delivered operational ramp-up in Q1 FY27 (= PARTIAL)
Investor Presentation filed with BSE, NSE: PRIVISCL. Summary written with AI assistance from the document.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,594.10
- Market cap
- ₹14,040 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 40.1×Sector 37.5×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 1.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Capital Structure Change
SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals announced an NCLT-convened meeting of equity shareholders for October 27, 2026, to consider the proposed Scheme of Amalgamation involving two transferor companies.
Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways
Privi reports 19.22% revenue growth and steady 24% EBITDA margins. Management maintains a confident outlook on expansion despite gross margin compression from high raw material costs compared to last year's low-cost base.
- Call
- Guides 100% growth
Privi Speciality Chemicals Q1 FY27 Results: Net Profit ₹82.8 Cr, Up 43.7% YoY
Privi Speciality Chemicals Ltd reported revenue from operations of ₹666.2 Cr (+19.2% YoY) and net profit of ₹82.8 Cr (+43.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹82.8 Cr · +43.7% YoY
Privi Speciality Chemicals Earnings Call: Key Takeaways
Privi reported strong FY26 performance with 22% revenue growth and 25.76% EBITDA margins, driven by volume growth and improved product mix.
Privi Speciality Chemicals Earnings Call: Key Takeaways
Privi delivered strong FY26 performance with 22% revenue growth and 25%+ margins. Management is pivoting from a '5k revenue' goal to a more aggressive long-term trajectory via high-value specialty molecules and backward integration.